124 related articles for article (PubMed ID: 7950781)
1. [The chronobiological aspects of drug resistance to antianginal therapy].
Arushanian EB; Shamliian TA
Eksp Klin Farmakol; 1994; 57(4):33-5. PubMed ID: 7950781
[TBL] [Abstract][Full Text] [Related]
2. [A mathematical analysis of the cardiac activity indices in patients with ischemic heart disease undergoing antianginal pharmacotherapy].
Arushanian EB; Shamliian TA
Eksp Klin Farmakol; 1995; 58(1):31-3. PubMed ID: 7787692
[TBL] [Abstract][Full Text] [Related]
3. [The detection of circadian fluctuations in the efficacy of pharmacotherapy in patients with ischemic heart disease using cardiointervalography].
Arushanian EB; Shamliian TA
Eksp Klin Farmakol; 1996; 59(2):24-6. PubMed ID: 8974558
[TBL] [Abstract][Full Text] [Related]
4. [Fluctuations in the stenocardia threshold of patients with ischemic heart disease].
Kuleshova EV; Gusarov GV; Tsaĭ NV
Ter Arkh; 1992; 64(4):23-6. PubMed ID: 1440301
[TBL] [Abstract][Full Text] [Related]
5. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
Makolkin VI; Vakhliaev VD
Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
[TBL] [Abstract][Full Text] [Related]
6. [The use of the new cardioprotective agent thiotriazoline in the therapy of ischemic heart disease in older patients].
Dunaev VV; Kraĭdashenko OV; Berezin AE
Eksp Klin Farmakol; 1996; 59(1):21-3. PubMed ID: 8704625
[TBL] [Abstract][Full Text] [Related]
7. Antianginal response to once-daily diltiazem CD in patients receiving concomitant beta-blockers, long-acting nitrates, or both. Diltiazem CD Study Group.
Heller GV; Sridharan M; Morse J; Glasser S; Beach CL
Pharmacotherapy; 1997; 17(4):760-6. PubMed ID: 9250554
[TBL] [Abstract][Full Text] [Related]
8. [The effect of helium-neon laser irradiation on myocardial and thyroid functions in patients with ischemic heart disease].
Ruzov VI; Rubanova MP; Grigor'ev MIu; Cherkunov KV
Vopr Kurortol Fizioter Lech Fiz Kult; 1997; (5):7-9. PubMed ID: 9446315
[No Abstract] [Full Text] [Related]
9. [Effect of various antianginal agents on the frequency and duration of myocardial ischemic episodes in patients with stable angina pectoris].
Voronkov LG; Lysenko AF
Kardiologiia; 1992; 32(11-12):67-70. PubMed ID: 1297887
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of patients with stable angina by combination of trinitrolong and propranolol].
Kukushkin SK; Metelitsa VI; Kokurina EV; Bochkarëva EV
Klin Med (Mosk); 1993; 71(5):30-3. PubMed ID: 8301980
[TBL] [Abstract][Full Text] [Related]
11. [A clinico-pharmacological study of the antianginal and anti-ischemic efficacy of a new drug form of diltiazem with delayed release].
Belousov IuB; Upnitskiĭ AA; Sokolov AV; Tishchenkova NF; Karasev AV; Egorova NA
Ter Arkh; 1997; 69(3):61-3. PubMed ID: 9229836
[No Abstract] [Full Text] [Related]
12. Effects of nifedipine retard on heart rate and autonomic balance in patients with ischemic heart disease.
Sato H; Arai H; Fukuda E; Tsutsumi Y; Yamamoto M; Aizawa T; Long-Tai FL
Int J Clin Pharmacol Res; 2001; 21(2):65-71. PubMed ID: 11824649
[TBL] [Abstract][Full Text] [Related]
13. [Clinical aspects of trimetazidine (preductal) administration as an antianginal drug].
Zhiliaev EV; Urzhumova TV; Glazunov AV; Sorokoletov SM; Dzhanashiia PKh
Ter Arkh; 2000; 72(8):20-3. PubMed ID: 11019420
[TBL] [Abstract][Full Text] [Related]
14. The relevance of sympathetic activity in the pharmacological treatment of chronic stable angina.
Singh BN
Can J Cardiol; 1999 Mar; 15 Suppl A():15A-21A. PubMed ID: 10205252
[TBL] [Abstract][Full Text] [Related]
15. Nifedipine in hypertension and heart failure.
Murakami E; Takekoshi N; Matsui S; Murakami H
Clin Ther; 1984; 6(2):205-36. PubMed ID: 6705014
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of dinitrate isosorbide retard forms in ischemic heart disease patients with stable effort angina].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Komar OA; Romasiuk SS; Naumov VG
Ter Arkh; 2000; 72(9):33-6. PubMed ID: 11076413
[TBL] [Abstract][Full Text] [Related]
17. [The tourniquet test in evaluating the analgesic action of antianginal preparations].
Zhiliaev EV; Glazunov AV
Ter Arkh; 1993; 65(4):40-3. PubMed ID: 8059406
[TBL] [Abstract][Full Text] [Related]
18. [Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
Butina EK; Kokurina EV; Dmitrieva NA; Bochkareva EV
Ter Arkh; 2002; 74(9):36-41. PubMed ID: 12418118
[TBL] [Abstract][Full Text] [Related]
19. [Cardiometabolic therapy of ischemic heart disease].
Vasil'ev AP; Strel'tsova NN; Senatorov IuN
Klin Med (Mosk); 2004; 82(4):59-62. PubMed ID: 15164513
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of circadian variation by combined antianginal therapy with suppression of morning and evening increases in transient myocardial ischemia.
Egstrup K
Am Heart J; 1991 Sep; 122(3 Pt 1):648-55. PubMed ID: 1877441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
